Hope E. Burks

766 total citations
27 papers, 417 citations indexed

About

Hope E. Burks is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Hope E. Burks has authored 27 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Hope E. Burks's work include Cancer Cells and Metastasis (7 papers), Histone Deacetylase Inhibitors Research (6 papers) and Epigenetics and DNA Methylation (4 papers). Hope E. Burks is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Histone Deacetylase Inhibitors Research (6 papers) and Epigenetics and DNA Methylation (4 papers). Hope E. Burks collaborates with scholars based in United States, Italy and China. Hope E. Burks's co-authors include Matthew E. Burow, Bridgette M. Collins‐Burow, Steven Elliott, Elizabeth C. Martin, Bruce A. Bunnell, Van T. Hoang, Margarite D. Matossian, Lyndsay V. Rhodes, Theresa B. Phamduy and Douglas B. Chrisey and has published in prestigious journals such as The Journal of Cell Biology, PLoS ONE and Cancer Research.

In The Last Decade

Hope E. Burks

26 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hope E. Burks United States	13	228	161	100	52	46	27	417
Karim Mrouj France	3	173 0.8×	102 0.6×	70 0.7×	34 0.7×	25 0.5×	5	366
Zhiqun Wu China	11	348 1.5×	237 1.5×	85 0.8×	34 0.7×	18 0.4×	27	517
Xun Sun China	14	303 1.3×	123 0.8×	140 1.4×	43 0.8×	29 0.6×	31	456
Siru Zhou China	9	294 1.3×	130 0.8×	100 1.0×	20 0.4×	25 0.5×	14	436
Stephen P. Berasi United States	11	335 1.5×	86 0.5×	92 0.9×	26 0.5×	25 0.5×	21	527
Esther López-Rivera United States	7	211 0.9×	96 0.6×	85 0.8×	42 0.8×	35 0.8×	8	461
W. Bouaziz France	7	274 1.2×	121 0.8×	96 1.0×	25 0.5×	21 0.5×	11	634
Lynn M. Opdenaker United States	10	190 0.8×	166 1.0×	69 0.7×	25 0.5×	22 0.5×	20	342
Pavlina Chuntova United States	10	177 0.8×	187 1.2×	83 0.8×	23 0.4×	63 1.4×	15	415
Teresita Reiner United States	13	285 1.3×	99 0.6×	85 0.8×	30 0.6×	33 0.7×	20	464

Countries citing papers authored by Hope E. Burks

Since Specialization

Citations

This map shows the geographic impact of Hope E. Burks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hope E. Burks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hope E. Burks more than expected).

Fields of papers citing papers by Hope E. Burks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hope E. Burks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hope E. Burks. The network helps show where Hope E. Burks may publish in the future.

Co-authorship network of co-authors of Hope E. Burks

This figure shows the co-authorship network connecting the top 25 collaborators of Hope E. Burks. A scholar is included among the top collaborators of Hope E. Burks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hope E. Burks. Hope E. Burks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tong, Xin, Hope E. Burks, Ziyou Ren, et al.. (2024). Crosstalk in Skin: Loss of Desmoglein 1 in Keratinocytes Inhibits BRAFV600E-Induced Cellular Senescence in Human Melanocytes. Journal of Investigative Dermatology. 145(7). 1740–1752.e4. 1 indexed citations

Burks, Hope E., Jenny L. Pokorny, Jennifer L. Koetsier, et al.. (2023). Melanoma cells repress Desmoglein 1 in keratinocytes to promote tumor cell migration. The Journal of Cell Biology. 222(11). 10 indexed citations

Roth‐Carter, Quinn R., Hope E. Burks, Ziyou Ren, et al.. (2023). Transcriptional profiling of rare acantholytic disorders suggests common mechanisms of pathogenesis. JCI Insight. 8(16). 9 indexed citations

Matossian, Margarite D., Khoa Nguyen, Celia Byrne, et al.. (2022). Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer. Frontiers in Molecular Biosciences. 9. 847505–847505. 5 indexed citations

Nguyen, Khoa, Hope E. Burks, Thomas Cheng, et al.. (2022). Abstract P3-05-07: The response of histone deacetylase inhibitors in triple negative breast cancer. Cancer Research. 82(4_Supplement). P3–5. 1 indexed citations

Burks, Hope E., Margarite D. Matossian, Lyndsay V. Rhodes, et al.. (2021). ZEB2 regulates endocrine therapy sensitivity and metastasis in luminal a breast cancer cells through a non-canonical mechanism. Breast Cancer Research and Treatment. 189(1). 25–37. 10 indexed citations

Matossian, Margarite D., Van T. Hoang, Hope E. Burks, et al.. (2021). Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer. Oncoscience. 8. 61–71. 2 indexed citations

Matossian, Margarite D., Steven Elliott, Lyndsay V. Rhodes, et al.. (2021). Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant‑resistant phenotype in breast cancer cells. Oncology Letters. 21(5). 380–380.

Matossian, Margarite D., Steven Elliott, Hope E. Burks, et al.. (2020). Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor. PLoS ONE. 15(10). e0226464–e0226464. 13 indexed citations

10.

Roth‐Carter, Quinn R., Lisa M. Godsel, Jennifer L. Koetsier, et al.. (2020). 225 Desmoglein 1 deficiency in knockout mice impairs epidermal barrier formation and results in a psoriasis-like gene signature in E18.5 embryos. Journal of Investigative Dermatology. 140(7). S26–S26. 3 indexed citations

11.

Burks, Hope E., et al.. (2019). Desmoglein 1 Regulates Invadopodia by Suppressing EGFR/Erk Signaling in an Erbin-Dependent Manner. Molecular Cancer Research. 17(5). 1195–1206. 23 indexed citations

12.

Roth‐Carter, Quinn R., Jennifer L. Koetsier, Joshua A. Broussard, et al.. (2019). Keratinocyte cadherin desmoglein 1 controls melanocyte behavior through paracrine signaling. Pigment Cell & Melanoma Research. 33(2). 305–317. 31 indexed citations

13.

Matossian, Margarite D., Hope E. Burks, Steven Elliott, et al.. (2019). Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model. BMC Cancer. 19(1). 205–205. 22 indexed citations

14.

Sabol, Rachel A., Annie C. Bowles, Rachel M. Wise, et al.. (2019). Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models. Breast Cancer Research. 21(1). 67–67. 53 indexed citations

15.

Anbalagan, Muralidharan, Yifang Zhang, Yuanjun Gao, et al.. (2017). Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression. Molecular Cancer Research. 15(11). 1491–1502. 13 indexed citations

16.

Matossian, Margarite D., Steven Elliott, Van T. Hoang, et al.. (2017). Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes. PLoS ONE. 12(8). e0177802–e0177802. 4 indexed citations

17.

Burks, Hope E., Nicholas C. Pashos, Elizabeth C. Martin, et al.. (2016). Endocrine disruptors and the tumor microenvironment: A new paradigm in breast cancer biology. Molecular and Cellular Endocrinology. 457. 13–19. 28 indexed citations

18.

Sweat, Richard S., Scott Stewart, Malwina Czarny‐Ratajczak, et al.. (2016). Aging is associated with impaired angiogenesis, but normal microvascular network structure, in the rat mesentery. American Journal of Physiology-Heart and Circulatory Physiology. 312(2). H275–H284. 11 indexed citations

19.

Rhodes, Lyndsay V., Chandra R. Tate, Van T. Hoang, et al.. (2015). Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1. Oncogenesis. 4(10). e168–e168. 26 indexed citations

20.

Rhodes, Lyndsay V., Chandra R. Tate, H. Chris Segar, et al.. (2014). Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators. Breast Cancer Research and Treatment. 145(3). 593–604. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact